Business ❯ Pharmaceutical Industry

Market Dynamics

Pricing Strategies Drug Pricing Drug Sales Drug Pricing Strategies Generic Drugs Drug Competition Stock Performance Cost Management Product Launch Export Trends Investment Trends Drug Development Investment Strategies Pricing Models Drug Costs Stock Market Impact Investor Reactions Pharmacy Benefit Managers Competitiveness Innovation China Vaccine Development Product Safety Export Strategies Import Regulations Sales Volumes Debt Issues Price Increases Sales Performance Patent Expiration Sales Forecasting Supplier Relations Weight Loss Drugs Biosimilar Development Anti-Obesity Medications Pricing Issues Competition Tariffs Supply Chain Issues Export Challenges Revenue Generation Drug Approval Process Consumer Access Cancer Therapies Price Control Innovation Strategies U.S. Market Supply Chain Stock Market Drug Demand Competitors Production Costs Investment Eli Lilly Digital Therapeutics Pricing Pressure Regional Market Share Product Protection Strategies Weight Loss Drug Market

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

The decision follows a Priority Review that cited modest benefit, with the alcohol-related safety warning unchanged.

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

FDA Approves Weekly Leqembi Autoinjector for At-Home Maintenance in Early Alzheimer’s

FDA Flags Possible License Revocation for Sarepta’s Elevidys